drugset / Trial / NCT06525740

Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery

NCT06525740

Phase 4 Recruiting 140 enrolled Mayo Clinic
RandomizedParallel-groupOpen-labelSupportive care

Summary

This phase IV trial compares methadone versus hydromorphone given in the fluid-filled space between the thin layers of tissue that cover the brain and spinal cord (intrathecal) for postoperative pain relief in patients with gynecologic cancer undergo surgery. Methadone binds to opioid receptors in the central nervous system and is a long-acting opioid pain medication. Intrathecal hydromorphone works by changing the way the brain and nervous system respond to pain and is similar to an epidural. This trial may help researchers determine if methadone works as well as intrathecal hydromorphone for pain relief after surgery in patients with gynecologic cancer.

Timeline

Start
2024-09-03
Primary completion
2029-09-01
Completion
2029-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydromorphone Other / unclassified Intrathecal
Subject Methadone Other / unclassified Intravenous